检索

标题
作者
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
Savchenko I., Stilidi I., Dzhanyan I., Antonova E., Polyakov A., Egorova A., Chulkova S., Breder V.
Therapy results of advanced-stag Hodgkin lymphoma in Khabarovsk district
Kanin V., Kanin E., Dolgaleva M.
Results of pelvic exenteration in patients with cervical cancer: clinical experience
Khakimov G., Khakimova G.
Targeted therapy for metastatic renal cell carcinoma
Porta C., Tsimafeyev I.
Efficacy of immunotherapy (Prolgolimab) and targeted therapy (Trametinib and Dabrafenib, Cobimetinib and Vemurafenib) in adult patients with metastatic or unresectable skin melanoma: matching-adjusted indirect comparison
Sapozhnikov K., Sokolova V., Sableva N., Tolkacheva D.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A., Fedyanin M., Pokataev I., Tyulyandin S.
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research
Kolomejtseva A., Bokova S.
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data
Bogdanov A., Moiseenko F., Egorenkov V., Bogdanov A., Volkov N., Fedyanin M.
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E., Zhukova L.
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K., Sultanbaev A., Musin S., Menshikova I., Nasretdinov A., Sultanbaeva N.
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Semiglazova T., Klyuge V., Semiglazov V., Teletaeva G., Krivorotko P., Dashyan G., Paltuev R., Tkachenko E., Donskikh R., Semiglazov V.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N., Vladimirova L., Kolyadina I., Frantsiyants E., Storozhakova A., Bandovkina V., Kalabanova E., Kabanov S., Svetitskaya I., Tishina A., Ezhova M.
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study
Zhurman V.
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis
Valiachmetova C., Siraev E., Izmailov A.
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes
Snegovoy A., Kononenko I.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I., Poddubnaya I.
1 - 18 的 18 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##